Neurodegenerative Disorders: Alzheimer's & Parkinson's Disease

Course Description & Information:

  • As many as one million Americans live with Parkinson's disease. Approximately 60,000 Americans are diagnosed with Parkinson's disease each year, and this number does not reflect the thousands of cases that go undetected. An estimated seven to 10 million people worldwide are living with Parkinson's disease. The incidence of Parkinson’s increases with age, but an estimated four percent of people with PD are diagnosed before the age of 50. An estimated 5.4 million Americans of all ages have Alzheimer’s disease (2016). This figure includes 5.2 million people aged 65 and older and 200,000 individuals under age 65 who have familial or early-onset Alzheimer’s. This course reviews pathology, diagnosis and current treatment options for both Alzheimer’s & Parkinson’s disease.
  • Pharmacist information: ACPE UAN: 0826-9999-16-017-L01-P, IRD: 12-20-16. Knowledge based activity.
  • Level: Intermediate
Course Objectives:

    At the end of the presentation, with regard to AZ and PD, the attendee should be able to:

  • Differentiate demographics of the diseases.
  • Describe some hallmark symptoms and biochemical changes seen in patients.
  • Explain the proteins thought to contribute to disease progression.
  • Associate genetic origins that appear to contribute to disease progression.
  • Explain current and potential pharmacologic interventions that are employed, or may be employed in the near future.

Course Credit: 2 Contact Hours

Accreditations: View Course Accreditations

Who Should Attend:

Pharmacists, Dietitians, Nursing professionals (2 hours of pharmacotherapeutic credit), Physical Therapy and Occupational Therapy professionals, and other medical professionals.

Certificate Requirements:

  • Full attendance.
  • Completion of course post-test (70%) and evaluation.

How to Take a Live Online Seminar: View Tutorial

Unlimited CE Membership: View Details

HTML5 Icon